Buy BPC-157 TB-500 UK | Wolverine Stack 10mg | Astra Labs

Buy BPC-157 TB-500 UK — Available Format

Astra Labs currently stocks BPC-157 TB-500 UK as a 10mg lyophilised research
vial blend. In addition, all stock is held domestically in the UK, which means
orders dispatch without international customs delays or overseas handling uncertainty.

What Is BPC-157 + TB-500?

BPC-157 + TB-500 is a research peptide blend that combines two
commonly studied compounds in a single vial. Specifically, BPC-157 is a synthetic
15-amino-acid peptide derived from a protective protein found in human gastric juice.
Furthermore, TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring
protein involved in cellular signalling research.

Astra Labs supplies BPC-157 + TB-500 10mg as a lyophilised research
compound. As a result, the product format provides long-term stability for laboratory
research purposes. The blend is supplied strictly for research use and is not for
human consumption, therapeutic use or medical application.

Quick Compound Facts

What Is the Wolverine Stack UK?

The term Wolverine Stack is widely used across the research peptide
community to describe a combined BPC-157 and TB-500 blend. Therefore, when UK buyers
search for “Wolverine Stack UK”, they are typically looking for the same combined
format Astra Labs supplies as BPC-157 + TB-500 10mg.

The name is informal and originated in online research peptide communities. Furthermore,
it reflects the fact that BPC-157 and TB-500 are commonly discussed together in the
same research context. As a result, suppliers that offer them as a combined blend often
market the product under both names.

When buyers search for Wolverine Stack UK specifically, the priority
signals they look for are: clear product presentation, UK domestic dispatch, transparent
research-use-only positioning, and visible COA documentation. Consequently, Astra Labs
positions the Wolverine Stack clearly as a laboratory research product with all four
signals visible on the product page.

BPC-157 vs TB-500 — Research Comparison

Many researchers searching to buy BPC-157 TB-500 UK also want to
understand how the two compounds differ. Therefore, the table below compares them
side-by-side across the dimensions that matter most in research contexts.

In summary, BPC-157 and TB-500 are structurally distinct compounds from different
biological origins. Consequently, researchers studying tissue-related signalling
pathways frequently investigate them together — which is exactly what the combined
blend format enables.

BPC-157 and TB-500 Research Overview

BPC-157 and TB-500 both appear frequently in published peptide research literature.
Furthermore, both compounds have generated significant scientific interest for their
roles in tissue-related and cellular signalling pathway research. However, this page
does not provide medical advice and does not make any treatment, performance or
therapeutic claims about either compound.

For broader scientific reading, researchers can explore published peptide literature
through
PubMed BPC-157 research
and
PubMed Thymosin Beta-4 research.
In addition, peer-reviewed publications provide the most reliable scientific context
for either compound.

Importantly, the key consideration for UK buyers is supplier transparency. Therefore,
when reviewing a BPC-157 TB-500 UK supplier, check whether the product page is clear,
whether the compound is positioned for research use only, and whether supporting
quality documentation such as third-party COAs is available.

What to Check Before You Buy BPC-157 TB-500 UK

Before you buy BPC-157 TB-500 UK, check that the supplier provides
enough information to make an informed decision. As a result, a professional UK
research peptide supplier should make key trust signals immediately accessible.

Buyer Checklist

Moreover, these checks help buyers compare BPC-157 TB-500 UK suppliers properly and
avoid low-quality sites with poor transparency, missing contact details, vague product
listings, or any supplier making medical or human-use claims.

BPC-157 TB-500 COA Verification — Janoshik Tested

A Certificate of Analysis is the most important document for any research peptide
purchase. Therefore, when buying BPC-157 + TB-500 in the UK, COA verification is
especially valuable because it confirms compound identity and purity for the combined
blend independently.

Astra Labs publishes a Janoshik third-party COA for the BPC-157 + TB-500
blend. Furthermore, the COA links directly from the product page to the Janoshik
verification platform — meaning buyers can independently confirm test results before
purchasing.

What the BPC-157 TB-500 COA Confirms

• ✅ Compound identity — both BPC-157 and TB-500 verified
• ✅ Purity percentage — independently measured
• ✅ Janoshik third-party testing — not self-reported
• ✅ Direct verification link — accessible from product page
• ✅ Batch traceability — unique test identifier

You can view all current test results on our
Certificates of Analysis hub. In addition,
the dedicated BPC-157 + TB-500 10mg product page
contains the latest Janoshik verification link.

UK Shipping When You Buy BPC-157 TB-500 UK

Astra Labs dispatches all BPC-157 + TB-500 orders from within the UK. Therefore,
buyers avoid customs delays, handling uncertainty and accountability gaps that come
with overseas-only suppliers. Moreover, every order ships in discreet, unmarked
packaging with fully secured checkout at every stage.

Shipping Summary

• ✅ Dispatched from within the UK — no international delays
• ✅ Discreet, unmarked packaging on every order
• ✅ Multiple shipping options available at checkout
• ✅ Secure, fully encrypted checkout process
• ✅ Fast dispatch on in-stock 10mg Wolverine Stack

In addition, choosing a UK-registered supplier means access to a verifiable business
through
Companies House
— an important accountability layer that overseas suppliers cannot match.

Is BPC-157 + TB-500 Legal in the UK?

Yes — it is legal to buy BPC-157 TB-500 UK for laboratory research
purposes. Neither BPC-157 nor TB-500 is a controlled substance under UK law. Therefore,
UK research suppliers can legally stock and sell the blend provided it is correctly
positioned for research use only.

However, neither compound is MHRA-approved for medical or therapeutic use in the UK.
Consequently, it cannot be marketed for human consumption or as a licensed medicine.
Any UK supplier making therapeutic claims about BPC-157 or TB-500 is operating outside
regulatory compliance and should be avoided.

For the full legal breakdown on UK peptide law in 2026, see our dedicated guide:
Are Peptides Legal in the UK? (2026).